In a major shift in the global fight against cancer, blood cancers are no longer viewed as the grim diagnoses they once were. Thanks to groundbreaking advancements in drug development, patients battling leukemia, lymphoma, and myeloma now have access to therapies that are not only extending life but improving its quality in ways once thought impossible. This rapidly evolving field is fueling...